COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0H0BF
|
|||
Drug Name |
Verdinexor
|
|||
Synonyms |
Verdinexor; Verdinexor (KPT-335); KPT-335; UNII-85Q03215IW; Verdinexor; VerdinexorKPT-335; Verdinexor (USAN/INN); EX-A871; KPT 335
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) | Investigative | [1] | |
Therapeutic Class |
Antiviral Agents
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H12F6N6O
|
|||
Canonical SMILES |
C1=CC=NC(=C1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F
|
|||
InChI |
1S/C18H12F6N6O/c19-17(20,21)12-7-11(8-13(9-12)18(22,23)24)16-26-10-30(29-16)6-4-15(31)28-27-14-3-1-2-5-25-14/h1-10H,(H,25,27)(H,28,31)/b6-4-
|
|||
InChIKey |
OPAKEJZFFCECPN-XQRVVYSFSA-N
|
|||
CAS Number |
CAS 1392136-43-4
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
1 | A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing. March 27, 2020. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.